DELL'ERA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 7.749
EU - Europa 3.733
AS - Asia 3.205
SA - Sud America 480
AF - Africa 57
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 15.244
Nazione #
US - Stati Uniti d'America 7.662
PL - Polonia 1.346
CN - Cina 1.202
SG - Singapore 1.021
UA - Ucraina 642
DE - Germania 448
BR - Brasile 405
HK - Hong Kong 362
IT - Italia 347
GB - Regno Unito 209
FI - Finlandia 208
VN - Vietnam 181
RU - Federazione Russa 127
IE - Irlanda 108
TR - Turchia 108
FR - Francia 106
IN - India 103
BD - Bangladesh 56
CA - Canada 46
ES - Italia 36
CZ - Repubblica Ceca 33
ID - Indonesia 33
AR - Argentina 32
SE - Svezia 30
MX - Messico 29
JP - Giappone 26
NL - Olanda 26
BE - Belgio 25
ZA - Sudafrica 23
EC - Ecuador 12
IQ - Iraq 12
MA - Marocco 11
PK - Pakistan 11
AT - Austria 10
CO - Colombia 10
SA - Arabia Saudita 10
TW - Taiwan 10
AU - Australia 9
EU - Europa 9
IR - Iran 9
VE - Venezuela 9
KR - Corea 8
CH - Svizzera 7
AZ - Azerbaigian 6
IL - Israele 6
LT - Lituania 6
UZ - Uzbekistan 6
KZ - Kazakistan 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
JO - Giordania 4
KG - Kirghizistan 4
PY - Paraguay 4
BG - Bulgaria 3
BO - Bolivia 3
EG - Egitto 3
KE - Kenya 3
NO - Norvegia 3
PT - Portogallo 3
SD - Sudan 3
TN - Tunisia 3
CL - Cile 2
HN - Honduras 2
JM - Giamaica 2
LB - Libano 2
MD - Moldavia 2
MU - Mauritius 2
PA - Panama 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
LK - Sri Lanka 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MS - Montserrat 1
MZ - Mozambico 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PW - Palau 1
RO - Romania 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 15.242
Città #
Warsaw 1.341
Fairfield 1.025
Woodbridge 797
Ashburn 676
Houston 500
Jacksonville 475
Singapore 473
Cambridge 412
Seattle 400
Ann Arbor 394
Wilmington 369
Hong Kong 351
Chandler 288
Beijing 243
Princeton 201
Nanjing 170
New York 134
Los Angeles 117
Helsinki 116
Dublin 107
The Dalles 107
Brescia 102
Dearborn 95
Chicago 93
Dallas 91
Istanbul 85
Munich 72
Dong Ket 62
Moscow 60
Buffalo 59
Changsha 58
Nanchang 53
San Francisco 51
Shanghai 51
São Paulo 46
Milan 44
Shenyang 43
Ho Chi Minh City 41
Jinan 41
Des Moines 39
San Diego 37
Hebei 36
Lancaster 35
Redondo Beach 35
Tianjin 34
Jiaxing 32
Hangzhou 27
Phoenix 27
Brussels 25
Boardman 24
Hanoi 24
London 24
Brooklyn 23
Tokyo 23
Jakarta 22
Kunming 22
Santa Clara 22
San Mateo 21
Taizhou 20
Tampa 20
Brno 19
Salt Lake City 19
Ningbo 18
Lanzhou 17
Chennai 16
Manchester 16
Stockholm 16
Augusta 15
Elk Grove Village 15
Leawood 15
Montreal 15
Vieste 15
Denver 14
Olomouc 14
Atlanta 13
Guangzhou 13
Haikou 13
Orem 13
Toronto 13
Turku 13
Belo Horizonte 12
Boston 12
Brasília 12
Poplar 12
Seveso 12
Zhengzhou 12
Barcelona 11
Fuzhou 11
Verona 11
Ankara 10
Mexico City 10
Norwalk 10
Mumbai 9
Porto Alegre 9
Walnut 9
Amsterdam 8
Bologna 8
Charlotte 8
Dhaka 8
Falkenstein 8
Totale 10.919
Nome #
Comparative analysis of mesenchymal stromal cells biological properties 334
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a KCNA5 p.D322H mutation 311
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 299
Generation and characterization of human cardiomyocytes derived from pluripotent stem cells 294
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 285
Generation and characterization of the human iPSC line IDISi001-A isolated from blood cells of a CADASIL patient carrying a NOTCH3 mutation 285
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes 278
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation 271
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 263
Clinical potentials of human pluripotent stem cells 255
Human iPSC-Derived 3D Hepatic Organoids in a Miniaturized Dynamic Culture System 245
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 238
Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM 229
Human derived cardiomyocytes: A decade of knowledge after the discovery of induced pluripotent stem cells 219
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 214
NOVEL GELATIN-BASED HYDROGELS FOR TISSUE ENGINEERING APPLICATION 199
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 198
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 197
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 195
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 195
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 188
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 181
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 181
MEMS force microactuator with displacement sensing for mechanobiology experiments 180
Preliminary Study of Inkjet Printed Sensors for Monitoring Cell Cultures 176
Biomanufacturing of a Chitosan/Collagen Scaffold to Drive Adhesion and Alignment of Human Cardiomyocyte Derived from Stem Cells 173
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 171
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 170
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 169
Preparation and assessment of high performance gelatin-based hydrogels for tissue engineering 166
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 164
Preparation and properties of high performance gelatin-based hydrogels with chitosan or hydroxyethyl cellulose for tissue engineering applications 163
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 162
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 160
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 159
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 157
Carbon on poly(ε-caprolactone) (PCL) ink-jet printed sensor for monitoring cell cultures of myoblasts 156
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 155
ELM: a new, simple, and economic assay to measure motility of lymphatic endothelial cells 153
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. 151
Autocrine role of basic fibroblast growth factor (bFGF) in angiogenesis and angioproliferative diseases 149
Generazione di cardiomiociti umani per lo studio di patologie cardiovascolari 148
Ink-jet printed stretchable sensors for cell monitoring under mechanical stimuli: A feasibility study 148
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 147
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 146
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations. 146
Using iPS cells toward the understanding of parkinson'€™s disease 142
Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells. 140
Increased frequency rate and alteration of If current in iPSC-derived atrial fibrillation human cardiomyocytes. 140
Prediction of abdominal aortic aneurysm calcification by means of variation of high-sensitivity C-reactive protein 140
Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises 137
Microstructured scaffold for guided cellular orientation: Poly(ε-caprolactone) electrospinning on laser ablated titanium collector 137
iPS, organoids and 3D models as advanced tools for in vitro toxicology 137
Arrangement of live human cells through acoustic waves generated by piezoelectric actuators for tissue engineering applications 134
FGF2-induced upregulation of DNA polymerase-delta p12 subunit in endothelial cells. 133
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 130
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 130
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 130
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 129
Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors 127
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 127
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. 127
iPS technology as a tool to investigate atrial fibrillation. 127
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 127
Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. 125
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 124
Fibroblast growth factor-2 in angiogenesis 123
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 123
Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis. 121
Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle. 121
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 120
Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver. 120
Microsample stiffness MEMS sensor for on-chip mechanobiology experiments 119
Atrial fibrillation modeling with iPSC derived cardiomyocyte 116
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 115
Differential expression of fibroblast growth factor receptors by human neurones, astrocytes and microglia. 115
Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. 113
Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy youngadults. 113
Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin. 112
iPSC-derived human cardiomyocytes from atrial fibrillation patients show increased frequency rate and alteration of If current 111
Sphingosine-1-phosphate receptor1 (S1P1) regulates venous vascular permeability via EphB4 receptor 110
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 106
Preliminary report: hiPSC reprogramming and karyotypic studies 105
Patient-derived IPSC as a tool to unravel molecular determinants of familial atrial fibrillation 104
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 103
hiPSC reprogramming and karyotypic alterations: a brief report 100
Functional and biochemical characterization of induced Pluripotent Stem cells (iPSCs) from patients with Neutral Lipid Storage Disease with Myopathy 100
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 99
iPS technology as a tool to investigate atrial fibrillation 99
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 94
Fibroblast growth factor receptor-1 and cardiomyocyte development in murine embryonic stem cells 94
A detailed characterization of the hyperpolarization-activated “funny” current (If) in human-induced pluripotent stem cell (iPSC)–derived cardiomyocytes with pacemaker activity 93
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 92
Role of FGFR1 in cardiovascular development:new insight from embryonic stem cells 90
Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. 83
Placental pericytes: the initial characterization shows similarities, as well as peculiar differences, with mesenchymal stem/stromal cells. 83
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration 79
Characterization of subcutaneous and visceral fat derived mesenchymal stromal cells 70
Fat-derived mesenchymal stromal cells: different sources, different properties 69
Generation of the induced pluripotent stem cell line UNIBSi017-A from an individual with cardiospondylocarpofacial syndrome and the MAP3K7 c.737-7A > G variant. 61
Totale 15.342
Categoria #
all - tutte 61.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.235 0 0 0 0 0 172 108 214 235 174 211 121
2021/2022941 61 201 16 17 10 56 51 57 41 133 72 226
2022/2023836 112 28 26 54 73 210 1 113 139 13 35 32
2023/2024838 57 21 95 42 43 111 32 38 205 19 27 148
2024/20252.047 26 19 5 280 180 185 158 48 266 132 521 227
2025/20262.405 394 471 303 519 545 173 0 0 0 0 0 0
Totale 15.498